On Friday, September 27, a woman suffering from mesothelioma, a cancer linked to asbestos exposure, and her husband were awarded $40.3 million by a California jury. Nancy Cabibi, 71, was a regular user of Johnson’s Baby Powder and Shower To Shower talc products, both of which are manufactured by J&J; according to documents filed with […]
On the eve of the consolidated trial set to begin in federal court in Cleveland, Ohio later this month, Johnson & Johnson and its subsidiary Janssen Pharmaceuticals have settled with Cuyahoga and Summit Counties for $20.4 million dollars. Under the terms of the agreement J&J is to pay $10 million in cash to the counties, […]
The first hearing in Purdue Pharma’s Chapter 11 bankruptcy filing was held on Tuesday September 17 before U.S. Bankruptcy Judge Robert Drain in White Plains, NY, two days after the drug maker filed for bankruptcy and just weeks before the first trial is scheduled to be held in the consolidated multidistrict opiate litigation in Cleveland, […]
There have been a number of developments in the wake of last week’s tentative settlement of over 2,000 lawsuits filed by a number of municipal governments and states in federal court in Cleveland against a number of defendants, including Purdue Pharma and its owners, the Sackler family. Under the terms of the settlement, in addition […]
Every day seems to bring new developments in the Juul story, with none of them good for Juul. On September 9, the U.S. Food and Drug administration issued a warning letter to Kevin Burns, the CEO of e-cigarette manufacturer JUUL Labs, Inc., for allegedly marketing the Juul device as a “modified risk tobacco product” without […]
Just weeks before the October 21 start of the first bellwether trial, Purdue Pharma, LP and its owners, the Sackler family, have reached a tentative settlement involving over 2,000 lawsuits filed by local municipalities, states and tribes in federal court in Cleveland; the deal is valued at up to $12 billion but does not cover […]
In a landmark ruling Monday afternoon, Cleveland County District Judge Thad Balkman found that corporate giant Johnson & Johnson and Janssen, its pharmaceuticals unit, had played a part in causing Oklahoma’s opioid crisis by using false and misleading marketing practices that exaggerated the benefits of their opioid painkillers Duragesic, a fentanyl patch, and Nucynta while […]
Drug manufacturers Endo International Plc and Allergan Plc have agreed to pay $15 million to two Ohio counties in an effort to avoid an upcoming trial pending in federal court in Cleveland. The two counties’ cases scheduled to proceed on October 21 were selected to comprise the first bellwether trial out of the multidistrict litigation […]
National Prescription Opiate Litigation – MDL 2804 At a hearing on June 25 held at the U.S. District Court for the Northern District of Ohio in Cleveland, Judge Polster, in response to concerns raised by distributors, pharmacies and state attorneys general, refrained from ruling on the plaintiffs’ attorneys’ motion to create a “negotiating class”, indicating […]
On June 14, attorneys representing local governments and communities met in Ohio and presented a proposed framework for a comprehensive nationwide settlement of the opioid crisis. Representing hundreds of counties, towns and municipalities, their goal is for impacted local communities to settle with the drug companies as a single “negotiating class” and effect a nationwide […]
